⌘K
t
Vulcan Two Group plc announced on 27 May 2026 that its Annual General Meeting (AGM) will be held at 2:00pm on Wednesday, 24 June 2026, at Canaccord Genuity Limited, 88 Wood Street, London. The Company's Annual Report and Accounts for the year ended 31 December 2025, along with the Notice of AGM, were made available to shareholders on its website and mailed to those who elected to receive hard copies.
| Date | 27 May 2026 |
| Time | 07:00:06 |
| Category | AGMs and other meetings |
| ID | 7754F |
27 May 2026
Vulcan Two Group plc
(the "Company" or "Vulcan Two")
Notice of Annual General Meeting and Posting of Annual Report
Vulcan Two Group plc, the company aiming to create the UK's leading regulated ePharmacy through buy and build, announces that the Company's Annual General Meeting ("AGM") will be held at 2:00pm on Wednesday, 24 June 2026 at Canaccord Genuity Limited, 88 Wood Street, London, EC2V 7QR.
The Annual Report and Accounts for the year ended 31 December 2025, together with the Notice of Annual General Meeting, have been made available to shareholders on the company's website at www.vulcantwo.com/investors
The Notice of the AGM, Annual Report, and Form of Proxy have been mailed to shareholders who have elected to receive hard copies.
For further information please contact:
|
Vulcan Two Group plc Michael Kraftman, Chief Executive Officer Keith Butcher, Chief Financial Officer Brendan O'Brien, Chief Operating Officer |
Email: [email protected]
|
|
Canaccord Genuity Limited Simon Bridges / Harry Pardoe / Elizabeth Halley-Stott |
Tel: +44 (0) 20 7523 8000 |
|
Alma Strategic Communications Justine James / Sam Modlin / Will Merison |
Email: [email protected] Tel: +44 (0) 20 3405 0205 |
Notes to Editors
Vulcan Two Group plc (AIM:VUL) is creating the UK's leading regulated ePharmacy platform, through its disciplined buy-and-build strategy. Following the acquisitions of CloudRx, Webmed and Hyperdrug in March 2026, the Group has established a diversified, profitable platform spanning B2B prescription fulfilment and B2C digital pharmacy services, with a high proportion of recurring revenues and strong cash generation. Future growth is expected to be supported through the acquisition of complementary businesses, expansion into new sectors or markets, and investment in long-term assets.
The Group is led by an experienced management team with deep healthcare, eCommerce and buy-and-build expertise.
For more information, visit www.vulcantwo.com